Dimebon - Study
Dimebon study, also known as Dimebon clinical trial, is currently being undertaken for the treatment of Alzheimer’s. There is also a phase II Dimebon study for the treatment of Huntington’s disease.
In the first Dimebon study for Alzheimer’s the results were very impressive. Dimebon showed huge benefits in patients with Alzheimer’s disease who received Dimebon. Dimebon also showed great benefit even for the caregivers of Alzheimer’s patients.
Due to the excellent results obtained in the original Dimebon study, further Dimebon studies are now underway. The current Dimebon study is known as the Connection Study and more information can be found at ConnectionStudy.com.
The current Dimebon Study, also known as the Connection Study, is a phase III clinical trial of 525 patients to test the effects of Dimebon in patients with Alzheimer’s. The goal of this Dimebon Study is to determine if Dimebon safely improves cognition (thinking and awareness), memory, daily functioning, behavior, and the ability to care for oneself. The Dimebon Study will also look at how Dimebon affects the lives of caregivers of individuals with Alzheimer’s who are taking the medicine.
It is our hope that the Dimebon Study will further prove the benefits of Dimebon in the treatment of Alzheimer’s